Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Big Yields in Big Pharma
Yahoo/IndieResearch
Monday, June 14, 2010 - 12:52pm
tags:
Abbott Laboratories, AstraZeneca, Baxter International, GSK, Eli Lilly, Bristol-Myers Squibb, Pfizer, JNJ, Novo Nordisk
Clinical Data takes bigger 4Q loss as costs rise
Yahoo/AP
Monday, June 14, 2010 - 12:50pm
tags:
Clinical Data, earnings
FDA wants more info on GlaxoSmithKline vaccine MenHibrix
Bizjournals.com
Monday, June 14, 2010 - 12:48pm
tags:
vaccines, MenHibrix, GSK, FDA
Bristol-Myers signs contracts with Parexel, Icon
Yahoo/AP
Monday, June 14, 2010 - 12:43pm
tags:
Bristol-Myers Squibb, Parexel, drug development, ICON
Launch of IMIDIA - An Innovative Medicines Initiative Project for Diabetes
Yahoo
Monday, June 14, 2010 - 12:41pm
tags:
IMIDIA, diabetes, AstraZeneca, Roche, Sanofi, Boehringer Ingelheim, Eli Lilly, Novartis, Novo Nordisk
Human Genome Hep C Drug Approval Unlikely: BioBuzz
TheStreet.com
Monday, June 14, 2010 - 12:37pm
tags:
Human Genome Sciences, hepatitis C, FDA, Zalbin
Why Is The Pharma Pipeline Clogged?
Forbes
Monday, June 14, 2010 - 12:20pm
tags:
pipelines
Common Blood Pressure Pills Linked To Cancer
Forbes
Monday, June 14, 2010 - 12:15pm
tags:
cancer, ARBs, Benicar, Daiichi Sankyo, Micardis, Boehringer Ingelheim, Merck, Cozaar, Novartis, Diovan
FDA Approval Positions Novartis in the Lead to Bring Oral MS Treatment to Market
Seeking Alpha
Monday, June 14, 2010 - 12:05pm
tags:
FDA, Novartis, MS, multiple sclerosis
Nautilus Neurosciences launches migraine drug Cambia in US
Pharmabiz
Saturday, June 12, 2010 - 10:32am
tags:
Nautilus Neurosciences, Cambia, migraines
How analysts view Parabolic Drugs IPO?
MyIris
Saturday, June 12, 2010 - 10:29am
tags:
Parabolic Drugs, IPOs
Hospira's biosimilar filgrastim gets EC approval to treat febrile neutropenia
Pharmabiz
Saturday, June 12, 2010 - 10:23am
tags:
Hospira, filgrastim, febrile neutropenia
AstraZeneca joins in sharing Alzheimer's data
The News Journal
Saturday, June 12, 2010 - 10:22am
tags:
AstraZeneca, Alzheimer's disease
Novotech CEO Speaks On - Clinical Projects: Faster and Smarter It's All in the Planning
EarthTimes
Saturday, June 12, 2010 - 10:19am
tags:
Novotech
Celgene International Sarl Releases Results of Phase II Study on Multiple Myeloma Patients
Trading Markets
Saturday, June 12, 2010 - 10:14am
tags:
Cellgene, Multiple Myeloma, dexamethasone, pomalidomide, lenalidomide
GSK acquires Argentine pharma firm Laboratorios Phoenix for $253 mn
Pharmabiz
Saturday, June 12, 2010 - 10:11am
tags:
GSK, M&A, generics
J&J execs were briefed on 'phantom recall' of Motrin
Yahoo/AP
Saturday, June 12, 2010 - 10:02am
tags:
JNJ, Motrin, recalls
Favorable Data on Xiaflex
Yahoo/Zacks
Saturday, June 12, 2010 - 10:00am
tags:
Auxilium, Xiaflex, Dupuytren's Contracture
Human Genome Seeks FDA Approval
Yahoo/Zacks
Saturday, June 12, 2010 - 9:59am
tags:
Human Genome Sciences, GSK, lupus, Benlysta
Big Pharma Rising: Barclays Likes BMY, MRK
Barron's
Saturday, June 12, 2010 - 9:57am
tags:
Bristol-Myers Squibb, Merck

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.